What XERF Multifrequency RF Actually Means for Your Skin
XERF is a non-invasive monopolar radiofrequency device that delivers energy at 6.78 MHz and 2 MHz through handpiece tips without needles or ablation. Preclinical studies in porcine tissue and small human trials have shown thermal effects in dermal and subdermal layers with short-term improvements in facial laxity, but these findings do not prove surgical-facelift effects or confirm treatment of the SMAS in humans. Outcomes, recovery, and suitability depend on the protocol, treatment settings, and individual patient factors.
XERF uses two radiofrequency modes, 6.78 MHz and 2 MHz, to heat tissue beneath the skin's surface without needles or ablation. Preclinical work in porcine tissue and early human studies suggest thermal effects in dermal and subdermal layers with short-term improvement in facial laxity. But those findings don't prove a surgical result or confirm that the device reaches the SMAS in humans.
How the Two Frequencies Work
XERF is a monopolar radiofrequency device. Energy travels from the handpiece through the skin to a grounding pad, heating tissue along the path. The FDA 510(k) summary describes both the 6.78 MHz and 2 MHz modes as non-invasive and delivered through treatment tips that don't break the skin.
Frequency affects penetration depth. Lower frequencies typically allow deeper energy delivery. Higher frequencies concentrate energy closer to the surface. XERF's dual-mode design gives practitioners two settings to work with, but depth in tissue depends on many variables beyond frequency alone.
Impedance, tissue hydration, fat thickness, and treatment parameters all influence where heat accumulates. XERF includes impedance feedback and adjustable parameters that can inform treatment delivery. These features do not prove improved outcomes or reduced risk for every patient. The practitioner must still select settings for the area, skin, medical history, and treatment objective.
What the Porcine Tissue Studies Tell Us
Preclinical histology used porcine skin to measure thermal effects after XERF treatment. Researchers reported heating in dermal and subdermal layers. Porcine tissue is a common model because its structure resembles human skin in thickness and collagen organization.
But porcine studies don't translate directly to human outcomes. Pig skin is thicker, hair follicles are denser, and fat distribution differs. Thermal conduction in live human tissue also varies by hydration, circulation, and individual anatomy.
The histology showed that energy reached deeper layers. It did not confirm what that heating produces in human facial laxity over time, or whether the depth is consistent across all patients. Preclinical data is a starting point, not a guarantee.
The Small Human Study and What It Showed
A prospective human study reported short-term improvement in facial laxity after XERF treatment. The study was small, and the follow-up period was limited. Those results are encouraging, but they don't prove a facelift effect or demonstrate that the technology treats the SMAS.
The SMAS is a fibromuscular layer that surgeons reposition during facelift procedures. Reaching it with radiofrequency energy in a meaningful, reproducible way is a different claim than heating the dermis or subcutaneous fat. No published evidence confirms that XERF contracts or repositions the SMAS in humans.
Short-term tightening can come from collagen contraction, mild edema, or immediate thermal effects that fade. Longer studies with larger patient groups and standardized assessment methods would clarify how much improvement persists and who benefits most.
What Dermal Heating Actually Does
Radiofrequency heats tissue. Heat denatures collagen fibers, causing immediate contraction. Over weeks to months, the injury response stimulates fibroblasts to produce new collagen. That process is called neocollagenesis.
The result, when it happens, is modest tightening and improved texture. The effect is cumulative and develops slowly, similar to what we see after other energy-based treatments like Clear + Brilliant.
Depth matters. Heating the papillary dermis improves texture and fine lines. Heating the deeper reticular dermis and subcutaneous layer can address laxity. But depth varies by treatment settings, tissue type, and how energy disperses in each individual.
Some protocols do not use topical anaesthetic. Treatment is commonly described as a controlled heating or warming sensation. Comfort varies by treatment area, settings, and individual sensitivity. The device is non-invasive and does not use microneedles or ablate the skin surface, which appeals to people who prefer to avoid needles, subject to individual suitability.
Who Might Be Suitable for XERF
XERF is positioned for patients with mild to moderate facial laxity who want a non-invasive option. It's not a replacement for surgery. Patients with advanced laxity, significant jowling, or loose neck skin typically see better results from surgical intervention.
Skin thickness, fat distribution, and tissue density all influence how well radiofrequency energy heats the target area. Thinner skin may respond faster but also carries higher risk for surface injury if settings aren't adjusted. Patients with more subcutaneous fat may require different parameters to reach the dermis effectively.
Medical history matters. Patients with implanted devices, metal in the treatment area, autoimmune conditions, or active skin infections may not be candidates. A thorough consultation establishes whether the treatment is appropriate.
How XERF Fits Into a Larger Skin Plan
Radiofrequency tightening works best when skin health is already supported. If barrier function is compromised, inflammation is high, or collagen synthesis is sluggish, the tissue won't respond as well to controlled injury.
We combine XERF with treatments that prepare and maintain the skin. Exosome facials support cellular signaling and repair pathways. Vitamin C serums like Rescue Serum stabilize new collagen. Retinoids upregulate collagen production over time, though you'll want to use them carefully to avoid thinning the skin before an energy treatment.
Hydration and barrier support are essential in the days following treatment. Daily Hydrating Cream helps skin recover without irritation. Sun protection is non-negotiable, since heated skin is more vulnerable to UV damage.
What You'll Actually Notice
Immediate tightening is subtle. Some patients see a slight lift right after treatment, but that's often temporary swelling or collagen contraction that relaxes within hours. Real improvement builds over eight to twelve weeks as new collagen forms.
The result is a firmer contour and improved texture, not a dramatic lifting effect. Jowls soften slightly. The jawline looks more defined. Skin feels denser. Those changes are visible in good light and in photographs, but they don't replicate what surgery achieves.
Most protocols recommend a series of treatments spaced four to six weeks apart. Maintenance sessions may be needed every six to twelve months or more often depending on age, skin quality, and lifestyle factors.
The Honest Limitations
XERF does not replace a facelift. It does not treat severe laxity, and it won't reposition sagging tissue the way surgery does. The porcine data and small human trial are early evidence, not proof of long-term efficacy or universal results.
Outcomes vary. Some patients see noticeable tightening. Others see minimal change. Factors like skin thickness, collagen density, age, and how tissue responds to heat all play a role. The practitioner's skill in selecting settings and treating the correct planes matters as much as the device itself.
Risks are generally mild but not absent. Swelling, redness, and temporary discomfort are common. Burns, fat atrophy, and uneven results can occur if settings are too aggressive or the treatment is applied incorrectly. Choosing an experienced provider reduces those risks, but no technology is foolproof.
When to Consider It
XERF makes sense for patients in their forties and fifties with early jowling, loss of jawline definition, or mild neck laxity who want a non-invasive option and understand the limitations. It also works well as maintenance after surgery, helping prolong the result without additional incisions.
Patients who want dramatic lifting or who have significant laxity are better candidates for surgery. Those looking for texture improvement, pore refinement, or pigmentation correction might benefit more from fractional laser treatments or exosome facials.
At the salons, we assess your skin, discuss your goals, and recommend treatments that match what your tissue can realistically achieve. Sometimes that's XERF. Often it's a combination of modalities layered over time to build a result that lasts.
Ready to see what's possible for your skin? Book an appointment at one of our New York or Los Angeles locations, or take the Skin Code Quiz to find the treatments and products that fit your goals.
Frequently asked questions
Does XERF actually reach the SMAS layer?
No published evidence confirms that XERF contracts or repositions the SMAS in humans. Preclinical porcine studies showed thermal effects in dermal and subdermal layers, but those findings don't prove that the device reaches or treats the SMAS reliably in human patients.
How does XERF compare to a surgical facelift?
XERF is not a replacement for surgery. It offers modest tightening and improved skin texture through collagen contraction and neocollagenesis, but it does not lift or reposition tissue the way a facelift does. Patients with advanced laxity or significant jowling typically see better results from surgical intervention.
Is XERF painful?
Treatment is commonly described as a controlled heating or warming sensation. Some protocols do not use topical anaesthetic. Comfort varies by treatment area, settings, and individual sensitivity. The device is non-invasive and does not use microneedles or ablate the skin surface.
How long do XERF results last?
Real improvement builds over eight to twelve weeks as new collagen forms. Most protocols recommend a series of treatments spaced four to six weeks apart. Maintenance sessions may be needed every six to twelve months, depending on age, skin quality, and lifestyle factors.
Who is a good candidate for XERF?
XERF is positioned for patients with mild to moderate facial laxity who want a non-invasive option. It works well for patients in their forties and fifties with early jowling or loss of jawline definition. Patients with advanced laxity, significant jowling, or loose neck skin typically see better results from surgical intervention. Medical history, skin thickness, and fat distribution all influence suitability.
Leave a comment